Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Bone Marrow Neoplasms × darinaparsin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 Lymphoid 1

Conditions

Lymphoma, T-Cell, Peripheral 2 Multiple Myeloma 1 Lymphoma, T-Cell 1 Lymphoma, Non-Hodgkin 1 Lymphoma 1 Hematologic Neoplasms 1 Carcinoma, Hepatocellular 1 Bone Marrow Neoplasms 1

Interventions

Bortezomib 2 darinaparsin 1 belinostat 1 SCIO-469 1 Lenalidomide 1 Dexamethasone 1 Cyclophosphamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00421213 2012-07-19

Phase II Study of ZIO-101 in Advanced Blood and Bone Marrow Cancers

Alaunos Therapeutics

Phase 2 Completed

LymphoidOther hematologic neoplasm

Lymphoma, Lymphoma, Non-Hodgkin, Lymphoma, T-Cell, Lymphoma, T-Cell, Peripheral, Bone Marrow Neoplasms, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡